Clinical trial
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
NCT04284436 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
- Lead sponsor
- Northwestern University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 30, 2021
- Completion date
- July 31, 2028
- Enrollment
- 370 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.